Showing results (11-20 of 367) with videos related to
Sort By:
Pageof 37
Kidney & Blood Pressure Research|June 12, 2004
Subpressor dose asymmetric dimethylarginine modulates renal function in humans through nitric oxide synthase inhibitionJ T Kielstein, S Simmel, S M Bode-Böger, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 1, 1993
Hypertension and the kidney--an overviewE Ritz, D FliserAmerican Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 3, 2001
Serum cystatin C concentration as a marker of renal dysfunction in the elderlyD Fliser, E RitzThe Clinical Investigator|January 1, 1992
Clinical relevance of albuminuria in hypertensive patientsE Ritz, D FliserJournal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|November 17, 1998
Does essential hypertension cause progressive renal disease?D Fliser, E RitzKidney International. Supplement|November 21, 2007
Erythropoiesis-stimulating agents: past and futureM Nangaku, D FliserGerontology|May 21, 1998
Relationship between hypertension and renal function and its therapeutic implications in the elderlyD Fliser, E RitzClinical Nephrology|November 5, 2004
Low dialysance of asymmetric dimethylarginine (ADMA)--in vivo and in vitro evidence of significant protein bindingJ T Kielstein, R H Böger, S M Bode-Böger, et al.European Journal of Clinical Investigation|May 29, 2008
Erythropoietin and the endothelium - a promising link?D Fliser, F H BahlmannPageof 37